Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis

Publisher： Karger

E-ISSN： 1421-9832|224|1|20-21

ISSN： 1018-8665

Source： Dermatology, Vol.224, Iss.1, 2011-11, pp. : 20-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin

By  

Dermatology, Vol. 232, Iss. 2, 2016-01 ,pp. : 249-253

Karger

Access to resources Recommend Favorite

Leflunomide Improves Psoriasis in Patients with Psoriatic Arthritis: An In-Depth Analysis of Data from the TOPAS Study

By  

Dermatology, Vol. 212, Iss. 3, 2006-04 ,pp. : 238-249

Karger

Access to resources Recommend Favorite

Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis

By  

Dermatology, Vol. 219, Iss. 3, 2009-09 ,pp. : 239-249

Karger

Access to resources Recommend Favorite

Intramuscular Alefacept Improves Health-Related Quality of Life in Patients with Chronic Plaque Psoriasis

By  

Dermatology, Vol. 206, Iss. 4, 2003-06 ,pp. : 307-315

Karger

Access to resources Recommend Favorite

Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 213-216

Karger

Access to resources Recommend Favorite